Search research articles
Contact Us
Filters
Showing results (141-150 of 156) with videos related to
Page
of 16
Sort By:
Genome Medicine
|
April 2, 2020
Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy
Anna Reustle, Moreno Di Marco, Carolin Meyerhoff, et al.
Circulation
|
August 31, 2019
Internal Versus External Electrical Cardioversion of Atrial Arrhythmia in Patients With Implantable Cardioverter-Defibrillator: A Randomized Clinical Trial
Jakob Lüker, Kathrin Kuhr, Arian Sultan, et al.
Breast Cancer Research and Treatment
|
February 23, 2013
Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant
Ofure Obazee, Christina Justenhoven, Stefan Winter, et al.
JAMA
|
October 8, 2009
Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen
Werner Schroth, Matthew P Goetz, Ute Hamann, et al.
Genome Medicine
|
September 15, 2022
A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy
Florian A Büttner, Stefan Winter, Viktoria Stühler, et al.
Brain : a Journal of Neurology
|
September 29, 2016
A de novo compound targeting α-synuclein improves deficits in models of Parkinson's disease
Wolfgang Wrasidlo, Igor F Tsigelny, Diana L Price, et al.
Pharmacological Research
|
December 5, 2025
Drug targeting of the monocarboxylate transporter MCT4 is a novel treatment strategy for metastatic ccRCC
Lena-Sophie Menig-Benzig, Viktoria Stühler, Pascale Mazzola, et al.
Frontiers in Genetics
|
June 20, 2013
The UGT1A6_19_GG genotype is a breast cancer risk factor
Christina Justenhoven, Ofure Obazee, Stefan Winter, et al.
Clinical Pharmacology and Therapeutics
|
January 11, 2023
Cross-Ancestry Genome-Wide Association Study Defines the Extended CYP2D6 Locus as the Principal Genetic Determinant of Endoxifen Plasma Concentrations
Chiea Chuen Khor, Stefan Winter, Natalia Sutiman, et al.
Ebiomedicine
|
September 13, 2020
Cell motility and migration as determinants of stem cell efficacy
Lusine Danielyan, Matthias Schwab, Georg Siegel, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 156) with videos related to
Sort By:
Page
of 16
Genome Medicine
|
April 2, 2020
Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy
Anna Reustle, Moreno Di Marco, Carolin Meyerhoff, et al.
Circulation
|
August 31, 2019
Internal Versus External Electrical Cardioversion of Atrial Arrhythmia in Patients With Implantable Cardioverter-Defibrillator: A Randomized Clinical Trial
Jakob Lüker, Kathrin Kuhr, Arian Sultan, et al.
Breast Cancer Research and Treatment
|
February 23, 2013
Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant
Ofure Obazee, Christina Justenhoven, Stefan Winter, et al.
JAMA
|
October 8, 2009
Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen
Werner Schroth, Matthew P Goetz, Ute Hamann, et al.
Genome Medicine
|
September 15, 2022
A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy
Florian A Büttner, Stefan Winter, Viktoria Stühler, et al.
Brain : a Journal of Neurology
|
September 29, 2016
A de novo compound targeting α-synuclein improves deficits in models of Parkinson's disease
Wolfgang Wrasidlo, Igor F Tsigelny, Diana L Price, et al.
Pharmacological Research
|
December 5, 2025
Drug targeting of the monocarboxylate transporter MCT4 is a novel treatment strategy for metastatic ccRCC
Lena-Sophie Menig-Benzig, Viktoria Stühler, Pascale Mazzola, et al.
Frontiers in Genetics
|
June 20, 2013
The UGT1A6_19_GG genotype is a breast cancer risk factor
Christina Justenhoven, Ofure Obazee, Stefan Winter, et al.
Clinical Pharmacology and Therapeutics
|
January 11, 2023
Cross-Ancestry Genome-Wide Association Study Defines the Extended CYP2D6 Locus as the Principal Genetic Determinant of Endoxifen Plasma Concentrations
Chiea Chuen Khor, Stefan Winter, Natalia Sutiman, et al.
Ebiomedicine
|
September 13, 2020
Cell motility and migration as determinants of stem cell efficacy
Lusine Danielyan, Matthias Schwab, Georg Siegel, et al.
Page
of 16